Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GP2013 (Rixathon) vs MabThera in Advanced Follicular Lymphoma
NCT01419665Phase 3Completed
- Sponsor
- Sandoz
- Start
- Dec 2011
- Primary completion
- Jul 2015
- Modality
- Monoclonal Antibodies
- Countries
- 26
01
Overview
A Phase 3 trial of rituximab in follicular lymphoma (FL), sponsored by Sandoz. Started Dec 2011; status: completed.
02
Drugs
rituximab
03
Conditions
follicular lymphoma (FL)
Beyond the preview
Go deeper on NCT01419665.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01419665.